• About
    • Mission
    • Leadership
    • Careers
    • Clinical Advisory Board
    • News
    • Media & Press
    • Events
  • Viveve Solutions
    • Viveve System
    • InControl
  • Healthcare Providers
    • Clinical Studies
    • Become a Provider
    • Manage Your Listing
    • Hub Login
    • FAQs
    • Product Feedback
  • Patients
    • Blog
    • Find A Provider
    • Refer A Provider
  • Investors
    • Overview
    • News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact Us
    • FAQs
    • Viveve Hub
    • Submit a Product Experience
  • Product Indication
Select Page
Viveve | US

Press Releases

Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • Publications
    • IR Calendar
    • Analyst Coverage
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Clinical Advisory Board
    • Medical Consultants
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Investor Presentation
    • Contacts
    • RSS News Feed
  • News / Events

  • Overview
  • Press Releases
  • Publications
  • IR Calendar
  • Analyst Coverage
  • Email Alerts

Viveve to Present at Raymond James Life Sciences and MedTech Conference

Jun 11, 2019

Viveve Reports First Quarter 2019 Financial and Operating Results

May 9, 2019

Viveve to Host Conference Call to Discuss First Quarter 2019 Financial and Operating Results on May 9, 2019

May 2, 2019

Viveve Announces CE Mark Clearance for its Next Generation 2.0 Platform in the European Union

Apr 11, 2019

Viveve Reports Fourth Quarter and Full Year 2018 Financial Results

Mar 14, 2019

Viveve Completes Enrollment in VIVEVE II Trial

Mar 11, 2019

Viveve to Host Conference Call to Discuss Fourth Quarter and Year-end 2018 Financial Results and Corporate Update on March 14, 2019

Mar 7, 2019

Viveve to Present at Cowen and Company 39th Annual Health Care Conference

Mar 5, 2019

Viveve Reports Preliminary Full Year 2018 Financial Results, Announces 2019 Revenue Guidance and Provides Corporate Update

Jan 16, 2019

Viveve Completes Enrollment in LIBERATE-International Trial for Improvement of Stress Urinary Incontinence

Jan 3, 2019
RSS
    • 1...
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • ...31

    Viveve

    A Global Women’s Intimate Health Company

    Terms of Use | Privacy Policy
    © 2021 Viveve Solutions. All Rights Reserved.

    • About
    • Viveve Solutions
    • Providers
    • Patients
    • Investors
    • Careers
    • Contact Us



    • Hub Login
    • Product Feedback

    345 Inverness Drive South
    Building B, Suite 250
    Englewood, CO 80112

    The Viveve System is indicated for general surgery for electrocoagulation and hemostasis in the United States.

    The Viveve® System is an internationally patented cryogen-cooled monopolar radiofrequency (CMRF) energy-based platform device. It has received regulatory approvals and clearances in many countries throughout the world and is available through physician import license in Japan and China. In the United States the Viveve System is cleared by the FDA for general surgery procedures for electrocoagulation and hemostasis. International approvals and clearances include vaginal laxity and/or improvement of sexual function indications. In Argentina improvement of urinary incontinence in women is also an approved indication.

    Translate »